News Website

Sequencing ADCs in Endometrial Cancer - OncLive

Sequencing ADCs in Endometrial Cancer OncLive

Published: May 12, 2026, 1:04 p.m.

Read Full Article

Unmet Needs in Endometrial Cancer - OncLive

Unmet Needs in Endometrial Cancer OncLive

Published: May 12, 2026, 12:59 p.m.

Read Full Article

Frozen Section in Endometrial Care? - Conexiant

Frozen Section in Endometrial Care? Conexiant

Published: May 12, 2026, 11:18 a.m.

Read Full Article

Overcoming Financial and Familiarity Barriers in Endometrial Cancer Management - Pharmacy Times

Overcoming Financial and Familiarity Barriers in Endometrial Cancer Management Pharmacy Times

Published: May 11, 2026, 2:03 p.m.

Read Full Article

Clinical Realities of Biomarker Utilization in Advanced Endometrial Cancer - Pharmacy Times

Clinical Realities of Biomarker Utilization in Advanced Endometrial Cancer Pharmacy Times

Published: May 11, 2026, 1:35 p.m.

Read Full Article

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows - MSN

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows MSN

Published: May 9, 2026, 10:45 p.m.

Read Full Article

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico - Cureus

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico Cureus

Published: May 9, 2026, 4:19 a.m.

Read Full Article

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma Nature

Published: May 8, 2026, 3:28 p.m.

Read Full Article

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.

Read Full Article

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

FDA clears new dual-target cancer drug for ovarian, endometrial trial Stock Titan

Published: May 7, 2026, 12:02 p.m.

Read Full Article

Latest Articles

Sequencing ADCs in Endometrial Cancer - OncLive

Unmet Needs in Endometrial Cancer - OncLive

Frozen Section in Endometrial Care? - Conexiant

Overcoming Financial and Familiarity Barriers in Endometrial Cancer Management - Pharmacy Times

Clinical Realities of Biomarker Utilization in Advanced Endometrial Cancer - Pharmacy Times

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows - MSN

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico - Cureus

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

Subscribe to Our Newsletter